Venus Remedies files for Patent in 48 countries for 2nd PCT Application

Venus Remedies Ltd has announced that the Company has successfully filed for Patent in 48 countries around the globe for the National Phase of its second PCT application for its Research Product, "Fixed Dose Combination of Latest Generation Cephalosporin with a Beta-Lactamase".

The Company had filed the Indian Patent for this innovative, broad spectrum antibiotic in 2004 and the PCT in November 2005, having now entered in its National Phase, the last step in the long chain of processes under PCT. The Company finalized and filed for Patent Protection of this novel formulation in 48 countries which have good market potential for this formulation, including the U.S, European Union, Japan, Middle-East, Brazil, Australia and New Zealand.

The product has been a volume builder ever since it's launch in domestic markets and is growing at a fast pace. Worldwide also, this product has a market size worth more than 1.00 billion USD.

The stock was trading at Rs.475, up by Rs.12.25 or 2.65%. The stock hit an intraday high of Rs.480 and low of Rs.455.25. The total traded quantity was 29548 compared to 2 week average of 17429.

Source : Equity Bulls

Keywords